(Reuters) - Eli Lilly on Friday was cleared of liability in the first trial involving claims that its antidepressant Cymbalta caused severe withdrawal symptoms, including suicidal thoughts and ...

The largest review of ‘gold standard’ antidepressant withdrawal studies to date has identified the type and incidence of symptoms experienced by people discontinuing antidepressants, finding most ...

A popular antidepressant, often known by the brand name Cymbalta, was recalled last week due to the presence of a potentially cancer-causing chemical. More than 233,000 bottles of duloxetine capsules ...

NEW YORK (MedscapeWire) Nov 26 — Data on duloxetine, an investigational balanced serotonin and norepinephrine reuptake inhibitor, suggest it is more effective than placebo and paroxetine in reducing ...